Liminal Biosciences Inc (LMNL)
3.81
-0.19 (-4.75%)
USD |
NASDAQ |
Mar 22, 16:00
3.81
0.00 (0.00%)
After-Hours: 18:40
Liminal Biosciences Gross Profit (Quarterly)
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2019 | 0.2384M |
| June 30, 2019 | 0.127M |
| March 31, 2019 | 0.8526M |
| December 31, 2018 | -5.620M |
| September 30, 2018 | 2.358M |
| June 30, 2018 | 2.905M |
| March 31, 2018 | -0.3753M |
| December 31, 2017 | -4.854M |
| September 30, 2017 | 16.16M |
| June 30, 2017 | 1.537M |
| March 31, 2017 | 1.870M |
| December 31, 2016 | 1.270M |
| September 30, 2016 | 1.445M |
| June 30, 2016 | 1.338M |
| March 31, 2016 | 2.518M |
| December 31, 2015 | 6.880M |
| September 30, 2015 | 3.406M |
| June 30, 2015 | 1.304M |
| March 31, 2015 | 0.8618M |
| December 31, 2014 | 7.203M |
| September 30, 2014 | 1.330M |
| June 30, 2014 | 2.195M |
| March 31, 2014 | 3.594M |
| December 31, 2013 | 2.928M |
| September 30, 2013 | 4.248M |
| Date | Value |
|---|---|
| June 30, 2013 | 3.314M |
| March 31, 2013 | 3.072M |
| December 31, 2012 | 6.475M |
| September 30, 2012 | 6.459M |
| June 30, 2012 | 4.926M |
| March 31, 2012 | 0.1428M |
| December 31, 2011 | 7.594M |
| September 30, 2011 | 2.966M |
| June 30, 2011 | 2.743M |
| March 31, 2011 | 2.437M |
| December 31, 2010 | 0.61M |
| September 30, 2010 | 1.916M |
| June 30, 2010 | 3.882M |
| March 31, 2010 | 1.926M |
| December 31, 2009 | 2.992M |
| September 30, 2009 | 2.417M |
| June 30, 2009 | -1.679M |
| March 31, 2009 | 2.757M |
| December 31, 2008 | 3.496M |
| September 30, 2008 | 2.165M |
| June 30, 2008 | 0.5822M |
| March 31, 2008 | 1.206M |
| December 31, 2007 | |
| September 30, 2007 | |
| June 30, 2007 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-5.620M
Minimum
Dec 2018
2.905M
Maximum
Jun 2018
0.0694M
Average
0.2384M
Median
Sep 2019
Gross Profit (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 27.07M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.0857M |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |